Apex Biotechnology Corp. (1733.TW)

TWD 30.7

(6.23%)

Market Cap (In TWD)

3.06 Billion

Revenue (In TWD)

1.67 Billion

Net Income (In TWD)

115.78 Million

Avg. Volume

369.75 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
27.05-44.45
PE
24.17
EPS
1.27
Beta Value
0.467
ISIN
TW0001733004
CUSIP
-
CIK
-
Shares
99950200.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Thomas Y. S. Shen Ph.D.
Employee Count
-
Website
https://www.apexbio.com
Ipo Date
2000-06-14
Details
Apex Biotechnology Corp. engages in the research, development, manufacture, and sale of home care medical devices by using biosensor technology worldwide. The company offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing, and hemoglobin screening systems. It also provides pesticide residues check systems; and care management and tele-health services. The company was founded in 1997 and is headquartered in Hsinchu City, Taiwan.